Skip to main content
Livermore
Livermore
ZHEN

Quadrant Capital Group LLC

SEC CIK
0001650717
Latest filing
Aug 14, 2026

GSK holding history

GSK plc in every 13F filed by Quadrant Capital Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GSK overviewAll 13F holders of GSKFull Q2 2026 holdings

Shares (Q2 2026)
49,444
Value
$2.59M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of GSK by Quadrant Capital Group LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202649,444$2.59M0.1%−707−1.4%ReducedHolders
Q1 202650,151$2.77M0.1%+999+2.0%AddedHolders
Q4 202549,152$2.41M0.1%+9,552+24.1%AddedHolders
Q3 202539,600$1.71M0.1%−22,482−36.2%ReducedHolders
Q2 202562,082$2.38M0.1%+5,183+9.1%AddedHolders
Q1 202556,899$2.20M0.1%+41,013+258.2%AddedHolders
Q4 202415,886$537.5K<0.1%−370−2.3%ReducedHolders
Q3 202416,256$664.8K<0.1%+798+5.2%AddedHolders
Q2 202415,458$595.3K<0.1%−1,872−10.8%ReducedHolders
Q1 202417,330$743.1K0.1%+601+3.6%AddedHolders
Q4 202316,729$620.2K0.1%−46−0.3%ReducedHolders
Q3 202316,775$608.3K0.1%+2,845+20.4%AddedHolders
Q2 202313,930$496.7K<0.1%−773−5.3%ReducedHolders
Q1 202314,703$523.3K0.1%+650+4.6%AddedHolders
Q4 202214,053$494.0K0.1%+10,320+276.5%AddedHolders
Q3 20223,733$110.0K<0.1%−8,149−68.6%ReducedHolders
Q2 202211,882$517.0K0.1%+2,806+30.9%AddedHolders
Q1 20229,076$395.0K<0.1%+656+7.8%AddedHolders
Q4 20218,420$371.0K<0.1%−472−5.3%ReducedHolders
Q3 20218,892$340.0K<0.1%+1,351+17.9%AddedHolders
Q2 20217,541$300.0K<0.1%+1,000+15.3%AddedHolders
Q1 20216,541$233.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.